Citadel Advisors - SONNET BIOTHERAPEUTC HLDNG I ownership

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 25 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q2 2022$4,000
-97.4%
15,642
-96.1%
0.00%
Q1 2022$153,000
-40.0%
405,622
+258.1%
0.00%
Q1 2021$255,000113,2640.00%
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q1 2022
NameSharesValueWeighting ↓
Campion Asset Management 90,612$34,0000.03%
Virtu Financial LLC 112,255$42,0000.00%
Ratio Wealth Group 22,500$8,4600.00%
TWO SIGMA SECURITIES, LLC 118,890$45,0000.00%
Renaissance Technologies 1,801,200$677,0000.00%
Advisory Services Network, LLC 50,525$19,0000.00%
Main Street Financial Solutions, LLC 10,657$4,0000.00%
JANE STREET GROUP, LLC 49,730$19,0000.00%
UBS Group AG 54,955$21,0000.00%
IFP Advisors, Inc 4,000$26,0000.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders